Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cayman Islands
Cayman Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.2% in 2024. ▼ Falling
Latest (2024)
0.2%
Change on year
unchanged
World rank
99th
of 247 countries
All-time high
0.4%
in 2015
All-time low
0.2%
in 2018
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cayman Islands, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cayman Islands stood at 0.2%. That is the lowest value across all 10 years on record.
The figure is down 50.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cayman Islands peaked at 0.4% in 2015 and was at its lowest, 0.2%, in 2018.
Cayman Islands ranks 99th of 247 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Cayman Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.2% | -33.3% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.2% | +0.0% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
Cayman Islands compared with similar countries
- Cayman Islands's 0.2% is above the median for Latin America & Caribbean, which is 0.2%, 1.3× the median. (40 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.4% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near Cayman Islands
- 99 Anguilla 0.2% compare
- 99 Antigua and Barbuda 0.2% compare
- 99 Aruba 0.2% compare
- 99 Bahamas 0.2% compare
- 99 Barbados 0.2% compare
- 99 Bonaire, Sint Eustatius and Saba 0.2% compare
- 99 British Virgin Islands 0.2% compare
- 99 Curaçao 0.2% compare
- 99 Dominica 0.2% compare
- 99 Fiji 0.2% compare
- 99 Grenada 0.2% compare
- 99 Guadeloupe 0.2% compare
- 99 India 0.2% compare
- 99 Jamaica 0.2% compare
- 99 Kazakhstan 0.2% compare
- 99 Libya 0.2% compare
- 99 Maldives 0.2% compare
- 99 Martinique 0.2% compare
- 99 Montserrat 0.2% compare
- 99 Nepal 0.2% compare
- 99 North Macedonia 0.2% compare
- 99 Pakistan 0.2% compare
- 99 Puerto Rico 0.2% compare
- 99 Saint Barthélemy 0.2% compare
- 99 Saint Kitts and Nevis 0.2% compare
- 99 Saint Lucia 0.2% compare
- 99 Saint Martin (French part) 0.2% compare
- 99 Saint Vincent and the Grenadines 0.2% compare
- 99 Sint Maarten (Dutch part) 0.2% compare
- 99 Suriname 0.2% compare
- 99 Tajikistan 0.2% compare
- 99 Turks and Caicos Islands 0.2% compare
- 99 United States Virgin Islands 0.2% compare
- 99 Venezuela (Bolivarian Republic of) 0.2% compare
- 99 Curacao 0.2% compare
More development goals data for Cayman Islands
- Red List Index 0.795 (2025)
- Number of refugees per 100,000 population, by country of origin 0 (2025)
- Manufacturing value added per capita 747.97 (2025)
- Alcohol consumption per capita (aged 15 years and older) within a 11.7 (2024)
- DEC alternative conversion factor 0.8333 (2024)
- Annual inflation, consumer prices -0.6% (2016)
- Number of victims of intentional homicide, by sex 3 (2020)
- Change in maximum river flow -20.8% (2024)
- Change in minimum river flow -46.1% (2024)
- River flow maximum 1.17 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cayman Islands?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Cayman Islands was 0.2% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Cayman Islands?
- The highest recorded value was 0.4% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Cayman Islands?
- The lowest recorded value was 0.2% in 2018.
- How does Cayman Islands rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cayman Islands ranks 99th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Cayman Islands?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this Cayman Islands data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).